DEA Compliance: Navigating Digital Identity Rules

The Drug Enforcement Administration (DEA) plays a critical role in regulating the handling of controlled substances. As telehealth and digital prescribing become increasingly common, ensuring DEA compliance presents new challenges. This guide provides a comprehensive overview of the requirements and how robust digital identity verification solutions can help your organization stay compliant when handling controlled substance prescriptions.

Key Takeaway 1 The DEA’s interim final rule on the electronic prescribing of controlled substances (EPCS) requires identity proofing and authentication for prescribers.

Key Takeaway 2 Telehealth providers prescribing controlled substances must adhere to the same DEA regulations as traditional in-person practices.

Key Takeaway 3 Implementing strong digital identity verification is crucial to prevent fraud and diversion of controlled substance prescriptions.

Key Takeaway 4 Failure to comply with DEA regulations can result in severe penalties, including fines, license revocation, and criminal charges.

Understanding the DEA’s EPCS Rule

In April 2021, the DEA issued an interim final rule addressing the electronic prescribing of controlled substance medications. This rule aimed to balance the benefits of electronic prescribing with the need to prevent drug diversion and abuse. A central component of the rule is the requirement for identity proofing and authentication of both prescribers and pharmacies. Prior to the rule, many EPCS systems lacked sufficient security measures to verify the identities of individuals involved in the process.

The EPCS rule mandates two-factor authentication (2FA) for all prescribers. This means they must provide two forms of identification, such as something they know (password) and something they have (a one-time code sent to their phone). Furthermore, prescribers must undergo robust identity proofing when initially registering with an EPCS system. This is where strong digital identity verification processes become essential.

Digital Identity Verification for Prescribers

The DEA does not prescribe a specific method for identity proofing, but it emphasizes the need for a high level of assurance. Acceptable methods typically include:

• Remote Identity Proofing: Utilizing technology to verify a prescriber’s identity remotely, often involving document verification, knowledge-based authentication (KBA), and biometric checks.
• In-Person Identity Proofing: Verifying a prescriber’s identity in person by a designated individual.

Remote identity proofing is particularly relevant for telehealth practices, where in-person verification is not feasible. Effective remote identity proofing solutions leverage multiple data points to establish a high degree of confidence in the prescriber’s identity. This includes verifying government-issued IDs, cross-referencing data with professional licensing boards, and utilizing biometric authentication methods like facial recognition. Didit’s Identity Verification and Biometric Verification modules can be combined to create a secure and compliant identity proofing workflow.

Telehealth and DEA Compliance

The rise of telehealth has significantly impacted the landscape of controlled substance prescribing. The DEA clarifies that the same regulations apply to prescribing controlled substances via telehealth as to in-person prescribing. This means that telehealth providers must adhere to all EPCS requirements, including identity proofing and 2FA. Special considerations apply to the establishment of a valid patient-physician relationship, which requires a prior in-person medical evaluation or a telehealth visit that meets specific criteria outlined by the DEA.

Furthermore, telehealth providers must ensure they are licensed to practice in the state where the patient is located. Interstate telehealth prescribing of controlled substance medications is subject to strict regulations and may require additional licensing or waivers. Regularly monitoring changes in state and federal regulations is crucial for maintaining ongoing DEA compliance.

Preventing Fraud and Diversion

Robust digital identity verification isn’t just about meeting regulatory requirements; it’s also about protecting patients and preventing the diversion of controlled substance medications. Fraudulent prescriptions can lead to addiction, overdose, and other serious health consequences. By implementing strong identity verification measures, healthcare providers can significantly reduce the risk of fraudulent prescribing and ensure that medications are going to legitimate patients.

Using tools like IP analysis and device fingerprinting can help flag suspicious activity and identify potential fraud attempts. For example, if a prescription is being submitted from an IP address associated with a known VPN or proxy server, it may warrant further investigation. Didit’s Fraud Signals module provides valuable insights to help identify and prevent fraudulent activity.

How Didit Helps

Didit provides a comprehensive digital identity platform designed to help organizations navigate the complexities of DEA compliance. Our platform offers:

• Secure Identity Verification: Verify prescriber identities with automated document verification, facial recognition, and knowledge-based authentication.
• Two-Factor Authentication: Integrate seamless 2FA into your EPCS workflow.
• Fraud Detection: Identify and prevent fraudulent prescriptions with real-time risk assessment and fraud signals.
• AML Screening: Screen prescribers and patients against global watchlists.
• Workflow Orchestration: Build custom verification flows tailored to your specific needs.

Didit's modular architecture allows you to select the features you need, providing a flexible and cost-effective solution for DEA compliance.

Ready to Get Started?

Ensure your organization is prepared for the evolving landscape of DEA compliance. Request a demo today to learn how Didit can help you protect your patients, prevent fraud, and stay compliant. You can also explore our pricing to find the right plan for your business.